Company / Interest Expense
Veracyte, Inc. Interest Expense History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$229.0K
FY2020
5-year range
-
FY2016-FY2020
Trend
-66.2%
vs FY2019
Sector context
#40 of 40
Health Care
What the data says
Among 40 Health Care companies, Veracyte, Inc. is in the top 0% for interest expense. Interest Expense has declined for 3 consecutive years, from $5M in FY2017 to $229,000 in FY2020.
Based on SEC 10-K filings.
$229,000 in FY2020 with a 3-year CAGR of -64.1%.
Improved from $2M to $229,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -64.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 40This company $229.0K Sector average $332.7M
▼
-99.9% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s interest expense has declined for 3 consecutive years.
- 3-year CAGR of -64.1%, indicating a declining trend.
- In FY2020, interest expense decreased 66.2% year-over-year.
- Ranks #40 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $229.0K | -66.2% |
| FY2019 | $677.0K | -65.5% |
| FY2018 | $2.0M | -60.3% |
| FY2017 | $4.9M | +79.2% |
| FY2016 | $2.8M | +629.4% |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026